Page last updated: 2024-10-30

loratadine and Leukemia

loratadine has been researched along with Leukemia in 1 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, T1
Hao, B1
Xu, S1
Meng, J1
Wen, T1
Liu, J1
Xu, H1

Other Studies

1 other study available for loratadine and Leukemia

ArticleYear
Effective RNAi in leukemia cells is enhanced by spermine-modified pullulan combined with desloratadine.
    Carbohydrate polymers, 2022, Sep-15, Volume: 292

    Topics: Glucans; Humans; Leukemia; Loratadine; RNA Interference; RNA, Small Interfering; Spermine

2022